Song et al. (2017) demonstrated that 30 out of 59 patients with medullary thyroid carcinoma exhibited membrane receptor GLP-1 expression, accounting for 50.8% of the studied cases [82]. This evidence concerns the gene GLP1R and medullary thyroid gland carcinoma.